This Isn't The Big One: Darzalex Wins US Approval In First-Line Multiple Myeloma

 
• By Eleanor Malone

Janssen Biotech has won FDA approval for Genmab-licensed Darzalex in newly diagnosed multiple myeloma. However, the drug was approved in a combination that is not commonly used in the US. A further label expansion will provide a bigger boost to the anti-CD38 antibody's commercial prospects.

SC1805_Night Sky_277897508_1200.jpg
Clinical Constellation: MAIA combo more relevant to US than ALCYONE trial • Source: Shutterstock

More from New Products

More from Scrip